Haemonetics (HAE) Tops Q2 EPS by 5c ; Offers Guidance
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $102.84 -0.08%
Revenue Growth %: +5.5%
Financial Fact:
Cost of goods sold: 116.01M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +5.5%
Financial Fact:
Cost of goods sold: 116.01M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $1.12, $0.05 better than the analyst estimate of $1.07. Revenue for the quarter came in at $346 million versus the consensus estimate of $342.58 million.
GUIDANCE:
Haemonetics sees FY2025 EPS of $4.45-$4.75, versus the consensus of $4.59.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Google and Blackstone data-center venture hits delays at key sites - Bloomberg
- Barnes & Noble Education (BNED) Tops Q1 EPS by 12c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
